Table 1.
Characteristics of the 62 patients studied.
| Mean age (years) | 64.7 (40–83) |
|---|---|
| FIGO 2009 stage | |
| IA | 14 (22.6 %) |
| IB | 18 (29 %) |
| II | 7 (11.3 %) |
| IIIA | 3 (4.8 %) |
| IIIB | 2 (3.2 %) |
| IIIC1 | 7 (11.3 %) |
| IIIC2 | 6 (9.7 %) |
| IVA | 3 (4.8 %) |
| IVB | 2 (3.2 %) |
| Pathological type | |
| Endometrioid | 52 (83.9 %) |
| Serous | 7 (11.3 %) |
| Clear cell | 2 (3.2 %) |
| Mixed | 1 (1.6 %) |
| Grade | |
| 1 | 7 (11.3 %) |
| 2 | 35 (56.5 %) |
| 3 | 20 (32.3 %) |
| Myometrial invasion | (58.1 %) |
| ≤ 50 % | 26 (41.9 %) |
| > 50 % | 36 (58.1 %) |
| VLSI | |
| No | 38 (61.3 %) |
| Yes | 20 (32.3 %) |
| NA | 4 (6.5 %) |
| Mean tumour size (cm) | 3.6 (1–10) NA-13 |
| Chemotherapy | |
| Carboplatin-paclitaxel 3 cycles | 3(4.8 %) |
| 4 cycles | 11(17.7 %) |
| 6 cycles | 10(16.1 %) |
| No | 38(61.3 %) |
| Lymph nodes involved | |
| Negative | 47(75.8 %) |
| Positive | 15(24.2 %) |
| Type of surgery | |
| Vaginal HBO + Pelvic ± PAo L | 20(32.3 %) |
| Abdominal HBO + Pelvic L | 8(12.9 %) |
| Abdominal HBO + Pelvic LAo | 5(8.1 %) |
| L + Ommentectomy, Exclusive HBO | 16(25.8 %) |
| Simple Hysterectomy | 3(4.8 %) |
| Other procedures | 10(16.1 %) |
VLSI: vascular and lymphatic space invasion, NA: not available. HBO: hysterectomy plus bilateral salpingo-oophorectomy PAo: Para-aortic, L:lymphadenectomy.